Receptor Agonist · $79.99 · 99%+ Purity · COA Verified
Fixed-ratio combination of Cagrilintide and Semaglutide. Dual amylin/GLP-1 receptor agonism studied for additive appetite-suppression pathway research.
Cagrisema is supplied as a research-grade lyophilized peptide for in-vitro laboratory study. Every batch is independently third-party tested by Freedom Diagnostics via HPLC and mass spectrometry, with a Certificate of Analysis available for each lot. Alphaomegatides fulfills orders within the United States only.
Verified 99%+ purity. Full Certificate of Analysis documentation is provided for Cagrisema, confirming identity and purity for reproducible research results.
View full Cagrisema details, COA, and reconstitution guidance →
All products are for in-vitro laboratory and scientific research use only. Not for human or veterinary use. Not evaluated by the FDA. US fulfillment only. Must be 21+.